Dergiler / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 1

Clinical Approach to Nanophthalmus: Diagnosis and Management Features

Sayfa
8–12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It should be considered additional medication and/or surgery may be required during follow-up.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: To evaluate the results of diagnostic features and management approaches in 4 cases with nanophthalmos.
📊
Temel Bulgular & Veri:Material and Methods: Four cases with nanophthalmos were evaluated retrospectively in terms of diagnostic features and treatment approaches.
💡
Sonuç & Katkı:It should be considered additional medication and/or surgery may be required during follow-up.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Purpose: To evaluate the results of diagnostic features and management approaches in 4 cases with nanophthalmos. Material and Methods: Four cases with nanophthalmos were evaluated retrospectively in terms of diagnostic features and treatment approaches. Three of the cases were siblings. Three siblings were female and the other was male. Bilateral laser iridotomy (LI) was applied to one of the sibling cases before being sent to our clinic. Argon laser peripheral iridoplasty (ALPI) was performed in two siblings in our clinic. The youngest sibling case was closely followed for glaucoma development. A trabeculectomy was performed in another center in the eye of the male patient with glaucomatous optic atrophy. Phacoemulsifi cation (Phaco) + viscogoniosynechialysis surgery was performed in the other eye of this patient, whose intraocular pressure (IOP) was not under control with maximal medical treatment. Results: No complications were encountered in the interventions to the cases. Additional medication (fi x combination) was needed during follow-up. Conclusion: Patients with nanophthalmos should be carefully monitored for glaucoma development with advancing age. Before the peripheral anterior synechia (PAS) develops, ALPI is valuable for IOP control. According to the degree of development of PAS in angle, synechialysis combined with phaco can provide signifi cant benefi ts in IOP control. However, all interventions to these cases are open to complication development, and close follow-up is required. It should be considered additional medication and/or surgery may be required during follow-up.

🔖

Bu Makaleye Atıf Yap

SARICAOĞLU, M. S. (2020). Clinical Approach to Nanophthalmus: Diagnosis and Management Features. Glokom Katarakt, Cilt: 15 - Sayı: 1, 8–12. https://ajindex.com/articles/226804

Kaynakça (15)

  1. Carricondo PC, Andrade T, Prasov L, et al. Nanophthalmos: A review of the clinical spectrum and genetics. J Ophthalmol. 2018:2735465:1-9
  2. Singh OS, Simmons RJ, Brockhurst RJ, et al. Nanophthalmos: a perspective on identifi cation and therapy. Ophthalmology 1982; 89: 1006–12
  3. Stewart DH 3rd, Streeten BW, Brockhurst RJ, et al. Abnormal scleral collagen in nanophthalmos. An ultrastructural study. Arch Ophthalmol 1991;109:1017–25
  4. Ritch R, Chang BM, Liebmann JM. Angle closure in younger patients. Ophthalmology 2003; 110: 1880–9
  5. Utman SA. Small eyes big problems: is cataract surgery the best option for the nanophthalmic eyes? J Coll Physicians Surg Pak. 2013;23(9):653-6
  6. Wu W, Dawson DG, Sugar A, et al. Cataract surgery in patients with nanophthalmos: results and complications. Cataract Refract Surg. 2004;30:584-90
  7. Yuzbasioglu E, Artunay O, Agachan A, et al. Phacoemulsifi cation in patients with nanophthalmos. Can J Ophthalmol 2009;44:534–9
  8. Jung KI, Yang JW, Lee YC, et al. Cataract surgery in eyes with nanophthalmos and relative anterior microphthalmos. Am J Ophthalmol 2012;153:1161– 8.e1 9. Singh H, Wang JC, Desjardins DC, et al. Refractive outcomes in nanophthalmic eyes after phacoemulsifi cation and implantation of a high-refractive-power foldable intraocular lens. J Cataract Refract Surg 2015;41:2394-2402
  9. Steijns D, Bijlsma WR, Van der Lelij A. Cataract surgery in patients with nanophthalmos Ophthalmology. 2013:266-70
  10. Zhang Z, Zhang S, Jiang X, et al. Combined 23-G Pars Plana Vitrectomy and lensectomy in the management of glaucoma associated with nanophthalmos. Ophthalmic Res. 2018;59:37-4
  11. Wladis EJ, Gewirtz MB, Guo S. Cataract surgery in the small adult eye. Surv Ophthalmol 2006;51:153–61
  12. Narvá ez J, Zimmerman G, Stulting RD, Chang DH. Accuracy of intraocular lens power prediction using the Hoffer Q, Holladay 1, Holladay 2, and SRK/T formulas. J Cataract Refract Surg 2006;32:2050–3
  13. Brockhurst RJ. Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol 1980; 98: 1987–90
  14. Jin JC, Anderson DR. Laser and unsutured sclerotomy in nanophthalmos. Am J Ophthalmol 1990; 109: 575–80
  15. Yalvac IS, Satana B, Ozkan G, et al. Management of glaucoma in patients with nanophthalmos. Eye (Lond). 2008;22:838-43.